Stock listing
DVHGF Stock Price, News, Filings & Events — Devonian Health Group, Inc.
Selected listing: DVHGF · OTC · USD · US
This page tracks Devonian Health Group, Inc.'s DVHGF:OTC listing on OTC in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DVHGF:OTC. DVHGF:OTC is the stock-level entry point for investors researching Devonian Health Group, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- DVHGF:OTC
- Asset type
- Stock
- Market cap
- $22.1M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OTC
- Currency
- USD
Devonian Health Group, Inc. DVHGF:OTC stock context
This page tracks Devonian Health Group, Inc.'s DVHGF:OTC listing on OTC in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DVHGF:OTC. DVHGF:OTC is the stock-level entry point for investors researching Devonian Health Group, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Devonian Health Group, Inc.
Devonian Health Group Strengthens Thykamine™ Manufacturing Platform with Validated Chemical-Composition Fingerprinting and Biological Pot...
September 1, 2026
Devonian Health Group Anticipates to Commence Trading on the NYSE American
August 18, 2026
Devonian Health Group Announces Proposed Listing on the NYSE American with Concurrent Underwritten Public Offering
July 27, 2026
Devonian Health Group Receives Health Canada Authorization to Initiate Phase II/III Pediatric Clinical Trial of Thykamine™ for Mild-to-Mo...
July 21, 2026
Devonian Health Group Reports Financial and Operating Results of its Three and Nine Months Ended April 30, 2026
June 29, 2026
Research Devonian Health Group, Inc.
Devonian Health Group, Inc. investor report
Review AI stock analysis and investor report context for DVHGF:OTC.
Devonian Health Group, Inc. company profile
View the public company page for Devonian Health Group, Inc. on 6ix.
Devonian Health Group, Inc. news
Read company news and market updates connected to Devonian Health Group, Inc..
Devonian Health Group, Inc. investor events
Find investor webinars, events, and replay context for Devonian Health Group, Inc..